logo
Loading...
Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2A) modulators
Medicine and HealthPLOS Computational Biology

Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2A) modulators

J. Peeters, D. D. Bundel, et al.

The serotonin-2A receptor's activation can relieve depression yet provoke hallucinations. Using multiple atomistic molecular dynamics simulations of 5-HT2A R bound to antipsychotics, non-hallucinogens and hallucinogens, the authors show modest receptor activation may produce antidepressant effects while excessive activation causes hallucinations. Research was conducted by Jordy Peeters, Dimitri De Bundel and Kenno Vanommeslaeghe.... show more
Abstract
The serotonin-2A receptor (5-HT2A R) is an interesting target for drug design in the context of antidepressants that might have a rapid onset of action and/or be effective in treatment-resistant cases. The main challenge, however, is that the activation of this receptor can provoke hallucinations. Recent studies have shown that activating the receptor with certain (partial) agonists could potentially give rise to antidepressant effect without hallucinogenic side effects. Although substantial research has been done in this area, the atomistic details of this differential activation of the serotonin-2A receptor are not fully understood. In the present study we performed multiple atomistic molecular dynamics (MD) simulations on 5-HT2A R bound with two antipsychotics, three different potential non-hallucinogens and two hallucinogens to identify the receptor’s ligand dependent conformations. Overall, our findings suggest that modest 5-HT2A R activation would only yield antidepressant effects and hallucinations result from excessive activation. While modest activation through microdosing may be problematic on account of abuse potential as well as possibly narrow and patientdependent therapeutic windows, modest activation through administration of a sufficiently weak partial agonist may offer a viable drug development pathway.
Publisher
PLOS Computational Biology
Published On
Sep 03, 2025
Authors
Jordy Peeters, Dimitri De Bundel, Kenno Vanommeslaeghe
Tags
5-HT2A receptorMolecular dynamics simulationsPartial agonistsAntidepressant mechanismsHallucinogenic side effectsLigand-dependent conformationsMicrodosing and therapeutic window
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny